What can biologic treatment do for patients with CRS with nasal polyps?
When Claus Bachert, MD, PhD, says “the patient is king,” what does that mean for his approach to treating CRS with nasal polyps? Watch as the editor of The Journal of Allergy and Clinical Immunology explains what access to biologics like DUPIXENT means for his patients and his practice.
Login to access this and all our premium content
New to Campus Sanofi? Register to access all our Content